Recent case-series of small size implied a pathophysiological association between coronavirus
disease 2019 (COVID-19) and severe large-vessel acute ischemic stroke. Given that …

… red-cell count was 0 per microliter (reference range, < 300), the glucose level was 4.4 mmol
per liter (2.2–3.9 mmol per liter), and the protein level was 0.3 g per liter (reference value, …

Background and Purpose—We sought to evaluate the effects of the combination of cytidine-5′-diphosphocholine
(citicoline) and thrombolysis on infarct size, clinical outcome, and …

Background Therapeutic hypothermia ( TH ) is a promising treatment of stroke, but limited
data are available regarding the safety and effectiveness of cooling methodology. We …

The effect of body temperature on cerebral infarcts and thrombolytic therapy was
investigated in 91 rats embolized in the right carotid territory. Hypothermia of 32C for 2 h with …

Many neuroprotective agents has been shown effective in experimental settings, but none
so far improved clinical outcome of acute ischemic stroke. Citicoline (CDP-choline, cytidine 5′…

Introduction Non-vitamin K-antagonist oral anticoagulants (NOAC) have become first choice
oral anticoagulant (OAC) with decreasing use of vitamin K antagonists (VKA), partly due to …

Efficacy and safety of combined α-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor
blockade and thrombolytic therapy with human recombinant tissue plasminogen activator (…

Introduction and Aim Data remain limited on sex-differences in patients with oral anticoagulant
(OAC)-related intracerebral hemorrhage (ICH). We aim to explore similarities and …

This study provides the first comprehensive quantification of translocator protein (TSPO)
binding using SPECT and 6-chloro-2-(4′- 123 I-iodophenyl)-3-(N,N-diethyl)-imidazo[1,2-a]…